10x Growth in GLP-1 Support Products CPG products positioned with GLP-1 soared 10x in 12 months Unique GTINs with GLP-1 positioning zoomed from 38 to 388 products in our catalog over the past year
Weeks 12: 2 mg once weekly Weeks 34: 4 mg once weekly Weeks 58: 8 mg once weekly Week 9+: 12 mg once weekly Efficacy and safety: The reason for the slow and gradual dosing protocol The Phase 2 clinical trial of retatrutide demonstrated that participants receiving the highest dose (12 mg) achieved up to 24% weight reduction after 48 weeks
The three approved injection sites are the abdomen (at least 2 inches away from the navel), the front of the thigh, and the upper outer arm
Its well-established roles are antioxidant defense, hepatic detoxification, and immune support
There was no additional risk above and beyond the high risk from diabetes.[ref] Risk rises over time: One problem with the epidemiological studies on Lp(a) is that most of them only last for 5 to 10 years, which may not be enough time to really determine causality
Medical Expert, The gastroparesis symptoms are side effects of GLP-1s